CDKN2AIP Antikörper (AA 301-400) (Biotin)
Kurzübersicht für CDKN2AIP Antikörper (AA 301-400) (Biotin) (ABIN706138)
Target
Alle CDKN2AIP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Verwendungszweck
- CDKN2AIP Polyclonal Antibody, Biotin Conjugated
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CARF
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- CDKN2AIP (CDKN2A Interacting Protein (CDKN2AIP))
-
Andere Bezeichnung
- CDKN2AIP
-
Hintergrund
-
Synonyms: Calcium response factor, CARF, CDKN2A interacting protein, CDKN2AIP, ALS2CR8, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein, Calcium-response factor, CaRF, Testis development protein NYD-SP24, AL2S8_HUMAN.
Background: CARF was first cloned as a novel binding partner of ARF from a yeast interactive screen. CARF and ARF colocalize in the perinucleolar region and have a collaborative function. In the nucleoplasm, CARF interacts with p53 and enhances its function. The p53 downregulates CARF in a negative feedback regulatory loop and may also involve p53 antagonist HDM2.
-
Gen-ID
- 55602
Target
-